Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study ; volume:18 ; number:1 ; day:15 ; month:7 ; year:2021 ; pages:1-6 ; date:12.2021
Harm reduction journal ; 18, Heft 1 (15.7.2021), 1-6, 12.2021
- Urheber
-
Goutzamanis, Stelliana
Horyniak, Danielle
Doyle, Joseph S.
Hellard, Margaret
Higgs, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-021-00516-1
- URN
-
urn:nbn:de:101:1-2021101723514576285653
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goutzamanis, Stelliana
- Horyniak, Danielle
- Doyle, Joseph S.
- Hellard, Margaret
- Higgs, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C
Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C
Correlation of host factor with virological response to direct-acting antiviral treatment in hepatitis C patients
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment
Effect of immunogenetics polymorphism and expression on direct-acting antiviral drug response in chronic hepatitis C